about
RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma developmentLineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers.VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma.Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases.Squamous cell carcinoma arising in a cutaneous epidermal cyst: case report and literature review.Primary epithelioid leiomyosarcoma of bone. Case report and literature review.Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cellsProliferating trichilemmal cyst with focal invasion: report of a case and a review of the literature.Cutaneous signet ring cell carcinoma: a report of a case and review of the literature.Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanomaMouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomesA humanized mouse model of HPV-associated pathology driven by E7 expressionRAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway.PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.[Cutaneous zygomycosis caused by Rhizopus arrhizus in a surgical wound.].Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.Cutaneous papillary squamous cell carcinoma. Report of three new cases and review of the literature.Metastasis of cutaneous malignant melanoma to angiolipoma: the tumor-to-tumor metastasis phenomenon.Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method.Primary cutaneous signet-ring cell melanoma: a clinico-pathologic and immunohistochemical study of two cases.Anencephaly and limb deficiencies.Messy granuloma: an additional pattern of granulomatous reaction.Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal ResistanceAnetoderma developing in juvenile xanthogranuloma.Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas.A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors.Sarcoidosis presenting as an osteolytic skull lesion: a case report and review of literature on skull sarcoidosis.Benign metastasizing giant-cell tumor of the hand. Report of a case and review of the literature.Superficial thrombophlebitis.Erythema nodosum leprosum: reactional leprosy.Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.Oncogenic KIT mutations in different exons lead to specific changes in melanocyte phospho-proteome.Morphologic clues in dermatopathology.Emergency dermatopathology.Necrosis of ears after use of cocaine probably adulterated with levamisole.Eosinophilic fasciitis as a manifestation of a cutaneous T-cell lymphoma not otherwise specified.Melanoma: diagnosis, staging, and treatment. Consensus group recommendations.Pediatric dermatofibrosarcoma protuberans in Madrid, Spain: multi-institutional outcomes.
P50
Q30657002-4CD08929-7CE6-4692-BB41-2676BD3BA1AFQ30829456-681083F1-A2FD-4F4F-82B9-905B3BED2A35Q31034658-75F190A7-9AF4-4B45-9378-8C6C502FB760Q33526634-19D6E553-AE27-409C-9E87-42229B32BE82Q33602950-77CB1D3A-C1D8-4A96-8503-F5C82A0DA13AQ33640093-E99285AE-2E25-4AE2-BB57-5689327A2AA4Q33775637-8BF5FBAB-AD62-40E2-BA45-CADF2A5705DDQ33894401-1C0E0FEC-5BCE-4D68-8EB9-057ABA62D515Q34324274-775CFF15-9B61-44EE-8618-C7543FF88828Q34346745-7A6B52BD-D391-448A-BBED-989D621F41E2Q34374191-2507CF7F-3FC3-485E-A5BF-5E25B36846A8Q34388174-F79C99ED-F8C8-464D-ABB5-CB6364B535E8Q34427215-BDA873FA-02B9-4879-8382-BD8811F13517Q34489388-2E9AC97D-AB77-4ABF-9B28-257D0334EAB7Q34656248-CFD53D5F-A382-4491-B41C-87B0F1AC7090Q35083250-CA6DBAA3-A23F-40E3-9EE4-748D2C6B83EFQ35088840-058BF08A-CE75-457F-80F7-7B8DD695349FQ35129857-CD6FBE5A-0AB3-4973-BFA2-6645211FEE9EQ35195417-C8BDA864-045E-4225-8FE7-960029A9CDD9Q35539181-327BAB3E-EB9A-4DDB-A9FE-56EF318E430DQ35804769-51E0128D-CFD4-4B48-BBAD-61211C479336Q36010353-3BF79F24-B8E7-415E-BB22-57ACD78C914BQ36022154-25D724CC-6340-41AB-A7E2-AAECDFE1B4D8Q36154735-078A124A-EFED-417C-8633-6DB4CD5B35B7Q36498356-2CA2ECD8-01D8-469D-882C-AA426AEAF11FQ36561739-212F4DDB-B301-40A7-9060-3CC2FB200387Q36568213-5FEAD987-0924-4443-BD92-73722C46DD5DQ36695264-17B9FE96-052D-4FDF-B027-3B53BBAD7B4DQ36698161-10E1479B-F73F-4D60-91D4-C5C1AB30AE1EQ36732111-39BBB74B-4E9C-48EB-8CF4-8A1AE432D84FQ36838544-65F3AA09-2E0B-4B25-94EB-6D557506BC6DQ36838566-73F70402-FE0D-4746-8F9A-04774C156F22Q37163606-2A3C9AC2-BA10-416E-88E1-1D2669F1BA98Q37262426-45011852-8D7B-48C7-860F-67593C3879BCQ37756374-AA120D1B-496F-499F-9FDA-CE9D6EE9709FQ37756378-72E90F5B-8FFB-4EA3-A76D-EFD7B323508FQ37918694-7946247E-8A05-4D63-8993-13BC47E3757BQ38113922-47FB6CE7-9485-4A47-B42F-8DE1B8142E3AQ38242004-6B29F57F-FA72-4F71-B0DB-FD84B5373EC8Q38271347-FEACAAD4-407E-45AA-A743-42130094264B
P50
description
researcher ORCID ID = 0000-0002-6578-7153
@en
name
José Luis Rodríguez-Peralto
@ast
José Luis Rodríguez-Peralto
@ca
José Luis Rodríguez-Peralto
@en
José Luis Rodríguez-Peralto
@es
José Luis Rodríguez-Peralto
@nl
type
label
José Luis Rodríguez-Peralto
@ast
José Luis Rodríguez-Peralto
@ca
José Luis Rodríguez-Peralto
@en
José Luis Rodríguez-Peralto
@es
José Luis Rodríguez-Peralto
@nl
prefLabel
José Luis Rodríguez-Peralto
@ast
José Luis Rodríguez-Peralto
@ca
José Luis Rodríguez-Peralto
@en
José Luis Rodríguez-Peralto
@es
José Luis Rodríguez-Peralto
@nl
P21
P31
P496
0000-0002-6578-7153